Study shows seladelpar beneficial for patients with primary biliary cholangitis
For patients with primary biliary cholangitis, more receiving the peroxisome proliferator-activated receptor delta (PPARδ) agonist seladelpar have a biochemical response and alkaline phosphatase normalization, according ...
Feb 27, 2024
0
0